A randomized controlled trial of a digital lifestyle intervention involving postoperative patients with colorectal cancer
- PMID: 40394118
- PMCID: PMC12092578
- DOI: 10.1038/s41746-025-01716-w
A randomized controlled trial of a digital lifestyle intervention involving postoperative patients with colorectal cancer
Erratum in
-
Author Correction: A randomized controlled trial of a digital lifestyle intervention involving postoperative patients with colorectal cancer.NPJ Digit Med. 2025 Jun 19;8(1):375. doi: 10.1038/s41746-025-01774-0. NPJ Digit Med. 2025. PMID: 40537524 Free PMC article. No abstract available.
Abstract
Few studies have investigated quality of life (QoL) improvements in patients with colorectal cancer or the benefits of digital healthcare interventions. This randomized controlled trial assessed the impact of mobile applications on postoperative QoL in patients scheduled for curative surgery for colorectal cancer. Patients were randomized into three intervention groups (each using a different mobile application for postoperative lifestyle management) and a control group. QoL was evaluated using the European Quality of Life-5 Dimensions (EQ-5D), with physical and metabolic parameters and fat/muscle areas measured preoperatively, and every six months postoperatively. At six months, no significant differences in the EQ-5D scores from baseline were observed across groups. Intervention Group C showed a significant increase in skeletal muscle area compared to the control group (P = 0.046). Overall, mobile application use had a minimal effect on postoperative health-related QoL, warranting further research on their efficacy and compliance rates. Trial registration: CRIS.nih.go.kr: KCT0005447. Registration date: June 23, 2020.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: The authors declare no competing interests.
Figures
References
-
- Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.71, 209–249 (2021). - PubMed
-
- Sauer, R. et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N. Engl. J. Med.351, 1731–1740 (2004). - PubMed
-
- Heald, R. J. & Ryall, R. D. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet1, 1479–1482 (1986). - PubMed
-
- Kapiteijn, E. et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N. Engl. J. Med. 345, 638–646 (2001). - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources